GenoCellEdit aims at promoting a tailored editing of cells’ genome, especially with the CRISPR system (Clustered Regularly Interspaced Short Palindromic Repeat)/Cas9, during which a specific nuclease is guided by a small RNA, called sgRNA. Having appeared in 2012, this molecular tool, by its simple design, has democratized the targeted approaches by genome modification. Because the project is not just the simple sgRNA design, GenoCellEdit platform provides a complete solution, from consulting in the design of the project to vectorization of the tool, and includes technical training.
After the opening of its office in Singapore, Keosys heads for the United States by opening an office in Philadelphia. Specializing in clinical routine and clinical trials and located on three continents (Europe, North America & Asia), the Nantes SME holds a leading international position in the field of medical imaging. Keosys, administrator of the cluster, is involved in Quanticardi and TheraneaM projects, both working within Atlanpole Biotherapies and is also involved in Isotop4Life in the radiopharmaceutical industry.
This year, the Thorax Institute celebrates its 10th anniversary. Led by Professor Hervé Le Marec, the Thorax Institute specializes in the research and care of cardiovascular, respiratory and metabolic diseases. It currently contributes to Nantes’ position as a stronghold of health research at national and international level. The Thorax Institute is a member of Atlanpole Biotherapies.
From 10 to 13 June, a dozen foreign students, selected on the basis of their motivation to put a value on their research, took part in an accelerated training in Nantes. They were led by professionals, to be enabled to create their start-up business. This multicultural group (from England, Eastern Europe, Sweden, China ...) working in the field of biotechnology, studied the themes of intellectual property, finance and funding sources, and finally produced a trial presentation.
9 Walloon companies and 19 companies from the Loire area met in Nantes at the beginning of June, under the impetus of Atlanpole Biotherapies and BioWin Walloon clusters, and supported by the Enterprise Europe Network. The objective of this mission was to draw partnerships between these 28 participants from the health area. After a presentation of European H2020 funding programs and participants, these professionals were able to visit either: Atlantic Bone Screen company, ARRONAX Cyclotron or Atlantic Bio GMP.
Dentaurum Ceramics is the ceramic research and manufacturing center of the Group Dentaurum GmbH and Co.KG, one of the European leaders in orthodontics and dentures. Established since 1994, in France near Angers, Dentaurum Ceramics develops and produces the Dentaurum group’s entire range of dental ceramics.